OTC: LBTSF - Almirall, S.A.

Yield per half year: -5.26%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Almirall, S.A.


About Almirall, S.A.

Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally.

more details
The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. Its products include Ilumetri, Solaraze, Actikerall, Ciclopoli, Skilarence, Aczone, Decoderm, Cordran Tape, Azelex, Klisyri, Tazorac, Seysara, Veltin, Almax, Ebastel, Sativex, Crestor, and Efficib/Tesavel. Almirall, S.A. has collaboration and partnership agreements with Tyris Therapeutics, BIOMAP, the University of Dundee, Kaken Pharmaceutical Co Ltd., Ichnos Sciences Inc., the University Carlos III Madrid and MEDINA Foundation, 23andMe, Inc., HitGen Ltd., WuXi Biologics, Eli Lilly and Company, and Athenex, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 2.08
Дивиденд ао 0.1833
Сайт https://www.almirall.com
Цена ао 9.01
Change price per day: 0% (9.01)
Change price per week: 0% (9.01)
Change price per month: 0% (9.01)
Change price per 3 month: -1.78% (9.173)
Change price per half year: -5.26% (9.51)
Change price per year: -5.26% (9.51)
Change price per year to date: -1.78% (9.173)

Underestimation

Title Value Grade
P/S 1.81 8
P/BV 1.23 9
P/E 384.08 1
EV/EBITDA 9.79 8
Total: 5.88

Efficiency

Title Value Grade
ROA, % -1.79 0
ROE, % -2.91 0
Total: 1.17

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0.7143 7.14
Total: 3.25

Debt

Title Value Grade
Debt/EBITDA 1.98 7
Total: 9.2

Growth impulse

Title Value Grade
Yield Revenue, % 18.65 3
Yield Ebitda, % -54.07 0
Yield EPS, % -139.53 0
Total: 0.6



Head Job title Payment Year of birth
Mr. Carlos Gallardo Piqué CEO, President, Member of Management Board & Chairman of the Board 53.55k 1972 (53 years)
Mr. Michael McClellan CFO & Member of Management Board N/A 1972 (53 years)
Mr. Eloi Crespo Cervera Chief Industrial Operations Officer & Member of Management Board N/A
Mr. Esteve Conesa Panicot Chief People & Culture Officer and Member of Management Board N/A
Dr. Volker Koscielny Chief Medical Officer & Member of Management Board N/A
Dr. Karl Ziegelbauer Chief Scientific Officer & Member of Management Board N/A
Mr. Paolo Cionini Chief Commercial Officer Europe & International and Member of Management Board N/A
Ms. Isabel Cristina Gomes Company Vice Secretary,Chief Legal Officer, General Counsel & Member of Management Board N/A
Ms. Mercedes Diz Lopez Chief Marketing Officer & Member of Management Board N/A
Mr. Pablo Divasson del Fraile Senior Director of Investor Relations N/A

Address: Spain, Barcelona, Ronda General Mitre. 151 - open in Google maps, open in Yandex maps
Website: https://www.almirall.com